Audrey M. Cordova

Audrey M. Cordova

Auto-generated profile, based on publicly available information

Audrey M. Cordova

Department of Internal Medicine, Division of Nephrology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, 73104, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2025 in Circulation Research
Verified
Journal Article
Closed access
TVThamizhiniyan Venkatesan
Thamizhiniyan Venkatesan
MTMaria Toumpourleka
Maria Toumpourleka
MNMonika Niewiadomska
Monika Niewiadomska
KFKassem Farhat
Kassem Farhat
LMLynsie Morris
Lynsie Morris
SSStavros Stavrakis
Stavros Stavrakis
BACKGROUND: We previously showed in a rat model of heart failure with preserved ejection fraction (HFpEF) that transcutaneous vagus nerve stimulation (tVNS) reduced cardiac fibrosis and inflammation. However, macrophage-mediated mechanisms through which tVNS rescues cardiac function remain poorly understood. METHODS: We induced HFpEF in 8-week-old mice by a combination of a high-fat diet and l -NG-nitro arginine methyl ester for 5 weeks, followed by 4 weeks of tVNS or sham stimulation. At this time, we analyzed cardiac function by echocardiography and immune cell numbers by single-cell RNA sequencing and flow cytometry. RESULTS: Our data demonstrate that HFpEF mice exhibited diastolic dysfunction, left ventricular hypertrophy, and fibrosis, consistent with HFpEF, and that tVNS significantly improved HFpEF severity. Analysis of merged single-cell RNA sequencing data from control, HFpEF+sham, and HFpEF+tVNS mice showed that HFpEF was associated with the accumulation of Spp1 -expressing CCR2 (C-C chemokine receptor type 2) + cardiac resident macrophages (CRM). Furthermore, treatment with tVNS reduced the number of CCR2 + CRM and the expression of Spp1 while also inducing the expression of Igf1 in TLF + (Timd4 + [T-cell immunoglobulin and mucin domain containing 4 + ]/Lyve1 + [Lymphatic vessel endothelial hyaluronan receptor 1 + ]/Folr2 + [Folate receptor 2 + ]) and MHC2 + (Major histocompatibility complex 2 + ) CRM. Global deletion of Spp1 or blockade of CCR2 + CRM recruitment improved HFpEF, whereas TLF + /MHC2 + specific deletion of Igf1 reversed the protective effect of tVNS on HFpEF. The benefits of tVNS were also abolished in the setting of disrupted acetylcholine/α7nAChR (α7 nicotinic acetylcholine receptor) signaling, either via pharmacological inhibition of α7nAChR or choline acetyltransferase deletion in CD4 + (cluster of differentiation) T cells. CONCLUSIONS: Collectively, our data indicate that tVNS improves HFpEF by reducing Spp1 expressing CCR2 + CRM and inducing expression of proreparative Igf1 in TLF + /MHC2 + CRM. These effects are mediated through cholinergic signaling, highlighting a neuroimmune pathway in HFpEF.

7 May 2026 in Kidney360
Verified
Journal Article
Open access
AYAlex Yashchenko
Alex Yashchenko
SMSarah J. Miller
Sarah J. Miller
ACAudrey M. Cordova
Audrey M. Cordova
MYMorgan E. Yashchenko
Morgan E. Yashchenko
SKShuja Khan
Shuja Khan
KZKurt A. Zimmerman
Kurt A. Zimmerman
Key Points: The rate and mechanism of kidney-resident macrophage niche filling differs between healthy and cystic mice. An incompletely filled kidney-resident macrophage niche is associated with worsened polycystic kidney disease outcomes. Background: Previous data indicate that bone marrow–derived Ly6c hi monocytes can become tissue-resident macrophages when the niche is available. However, the balance between monocyte recruitment and tissue-resident macrophage self-proliferation following partial depletion is unclear. Methods: We investigated the kinetics and mechanism of kidney-resident macrophage (KRM) niche filling in healthy mice and in a mouse model of autosomal dominant polycystic kidney disease after partial depletion with liposomal clodronate. Results: Our data indicate that healthy mice efficiently refilled their KRM niche through monocyte-dependent recruitment, engraftment, and differentiation while cystic mice relied preferentially on in situ KRM self-proliferation for niche filling. Furthermore, we found sex-specific differences in niche-filling capacity in cystic mice as female, but not male, mice were unable to completely fill their niche 90 days postdepletion. The inability of cystic female mice to fill the niche following depletion was likely due to their reduced ability to recruit monocytes and convert them into KRM. Phenotypically, delayed KRM niche filling was associated with worsened outcomes including increased cystic index and kidney fibrosis as well as worsened kidney function. Conclusions: Collectively, our data demonstrate that sex and disease status affect the kinetics and mechanism of niche filling in the kidney.